Maxcyte, Inc.
MXCT- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001287098
No open-market purchases or sales by Maxcyte, Inc. insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $78.0M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Maxcyte, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 99
- −5 vs. Q4 2021
- Shares held
- 68.6M
- +1.49M (+2.2%) vs. Q4 2021
- Total value
- $479.8M
- −$203.9M (−29.8%) vs. Q4 2021
- New holders
- 17
- 37 more added
- Sold out
- 22
- 34 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MXCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $78.0M |
| Q1 2026 | 132 | $46.2M |
| Q4 2025 | 112 | $98.0M |
| Q3 2025 | 112 | $110.8M |
| Q2 2025 | 120 | $155.5M |
| Q1 2025 | 115 | $193.8M |
| Q4 2024 | 119 | $301.9M |
| Q3 2024 | 120 | $267.4M |
| Q2 2024 | 114 | $268.0M |
| Q1 2024 | 124 | $280.8M |
| Q4 2023 | 121 | $316.1M |
| Q3 2023 | 120 | $200.8M |
| Q2 2023 | 116 | $303.3M |
| Q1 2023 | 115 | $327.9M |
| Q4 2022 | 105 | $377.7M |
| Q3 2022 | 109 | $453.8M |
| Q2 2022 | 104 | $322.7M |
| Q1 2022 | 99 | $479.8M |
| Q4 2021 | 104 | $683.6M |
| Q3 2021 | 81 | $665.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Maxcyte, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 0 | $0 | 0.00% | −986,437−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −293,452−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −141,027−100.0% | Sold out |
| BlueCrest Capital Management Ltd | 0 | $0 | 0.00% | −44,819−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −34,220−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −33,775−100.0% | Sold out |
| Rock Creek Group, LP | 0 | $0 | 0.00% | −52,684−100.0% | Sold out |
| Exane Derivatives | 0 | $0 | 0.00% | −27,307−100.0% | Sold out |
| M&T Bank Corp | 0 | $0 | 0.00% | −24,742−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −22,800−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −20,670−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −20,500−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −17,627−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −16,006−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −14,910−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −11,788−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −579−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −243−100.0% | Sold out |
| Quilter Plc | 0 | $0 | 0.00% | −4,400−100.0% | Sold out |